Metronidazole

Actavis Has Acquired Worldwide Rights for Valeant's Metronidazole 1.3% Gel Antibiotic
May 7, 2013
Actavis Specialty Brands has acquired worldwide rights for Valeant's Metronidazole 1.3% vaginal gel antibiotic development product for approximately $55m. Metronidazole 1.3% vaginal gel antibiotic development product is a topical ...

Tags: Actavis, Metronidazole, Gel Antibiotic
Pylori Gastritis Using Triple Therapy with Proton Pump Inhibitor
Feb 25, 2013
Takeda Pharmaceutical Company has announced the approval of Helicobacter pylori Gastritis as an additional indication to eradicate Helicobacter pylori using triple therapy with proton pump inhibitor by Japan's Ministry of Health, Labour and ...

Tags: Helicobacter pylori Gastritis, Helicobacter pylori eradication
FDA Announce Could Leave Many People Searching for Alternatives
Feb 5, 2013
The shortage of doxycycline recently announced by the Food and Drug Administration could leave many people searching for alternatives because the antibiotic is used to treat a wide range of conditions that afflict millions, including acne, ...

Tags: doxycycline, Food and Drug Administration, antibiotic